miR-622 specifically targets and downregulates FOLR2, which could in turn attenuated miR-622-induced tumor growth, suggesting a novel mechanism and treatment target in CRC epigenetic regulation. The gene discussed is FOLR2; the disease is colorectal carcinoma.